Maternal serum perlecan levels in women with preeclampsia

References

• American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1–25.
   PubMed Web of Science ®Google Scholar
• Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376:631–644.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ. 2013;347:f6564.
   PubMed Web of Science ®Google Scholar
• Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56–59.
   PubMed Web of Science ®Google Scholar
• Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22(2):203–212.
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. PIERS Study Group. Lancet. 2011;377:219–227.
   PubMed Web of Science ®Google Scholar
• Stergiotou I, Crispi F, Valenzuela-Alcaraz B, et al. Patterns of maternal vascular remodeling and responsiveness in early- versus late-onset preeclampsia. Am J Obstet Gynecol. 2013 Dec;209(6):558.e1–558.e14.
   PubMed Web of Science ®Google Scholar
• Ogge G, Chaiworapongsa T, Romero R, et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med. 2011;39(6):641–652.
   PubMed Web of Science ®Google Scholar
• Sunderji S, Gaziano E, Wothe D, et al. Automated assays for sVEGFR1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol. 2010;202(1):40–47.
   PubMed Web of Science ®Google Scholar
• Valensise H, Vasapollo B, Gagliardi G, et al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873–880.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL, Staff AC. IFPA senior award lecture: making sense of pre-eclampsia— two placental causes of preeclampsia? Placenta. 2014;35(Suppl):S20–5.
   PubMed Web of Science ®Google Scholar
• Iozzo RV. Perlecan: a gem of a proteoglycan. Matrix Biol. 1994;14(3):203–208.
   PubMed Web of Science ®Google Scholar
• Kinsella MG, Wight TN. Perlecan: an extracellular matrix heparan sulfate proteoglycan that regulates key events in vascular development and disease. In: Garg HG, Linhardt RJ, Hales CA, editors. Chemistry and biology of heparin and heparan sulfate. Amsterdam (Netherlands): Elsevier Ltd; 2005. p. 607–635.
   Google Scholar
• Martinez JR, Dhawan A, Farach-Carson MC. Modular proteoglycan perlecan/HSPG2: mutations, phenotypes, and functions. Genes (Basel). 2018;9(11):E556.
   PubMed Web of Science ®Google Scholar
• Nikkari ST, Järveläinen HT, Wight TN, et al. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994;144(6):1348–1356.
   PubMed Web of Science ®Google Scholar
• Tran PK, Agardh HE, Tran-Lundmark K, et al. Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions. Atherosclerosis. 2007;190(2):264–270.
   PubMed Web of Science ®Google Scholar
• Ning L, Xu Z, Furuya N, et al. Perlecan inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle. Matrix Biol. 2015;48:26–35.
   PubMed Web of Science ®Google Scholar
• Nakashima A, Aoki A, Kusabiraki T, et al. Autophagy regulation in preeclampsia: pros and cons. J Reprod Immunol. 2017;123:17–23.
   PubMed Web of Science ®Google Scholar
• Chui A, Murthi P, Brennecke SP, et al. The expression of placentalproteoglycans in pre-eclampsia. Gynecol Obstet Invest. 2012;73(4):277–284.
   PubMed Web of Science ®Google Scholar
• Szenasi NL, Toth E, Balogh A, et al. Proteomic identification of membrane-associated placental protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies. PeerJ. 2019;7:e6982.
   PubMed Web of Science ®Google Scholar
• Guo HX, Zhu YB, Wu CP, et al. Potential urine biomarkers for gestational hypertension and preeclampsia. Mol Med Rep. 2019;19(4):2463–2470.
   PubMed Web of Science ®Google Scholar
• Douglass S, Goyal A, Iozzo RV. The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy. Connect Tissue Res. 2015;56(5):381–391.
   PubMed Web of Science ®Google Scholar
• Yang WC, Su TH, Yang YC, et al. Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta. 2005;26(10):780–788.
   PubMed Web of Science ®Google Scholar
• Carson DD, Tang JP, Julian J. Heparan sulfate proteoglycan (Perlecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol. 1993;155(1):97–106.
   PubMed Web of Science ®Google Scholar
• Brosens I, Pijnenborg R, Vercruysse L, et al. The “great obstetrical syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
   PubMed Web of Science ®Google Scholar
• Rohde LH, Janatpore MJ, McMaster MT, et al. Complementary expression of HIP, a cell-surface heparan sulfate binding protein, and perlecan at the human fetal-maternal interface. Biol Reprod. 1998;58(4):1075–1083.
   PubMed Web of Science ®Google Scholar
• Bix G, Iozzo RV. Novel interactions of perlecan: unraveling perlecan’s role in angiogenesis. Microsc Res. 2008;71(5):339–348.
   PubMed Web of Science ®Google Scholar
• Nakashima A, Yamanaka-Tatematsu M, Fujita N, et al. Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia. Autophagy. 2013;9(3):303–316.
   PubMed Web of Science ®Google Scholar
• Kanninen TT, Jayaram A, Jaffe Lifshitz S, et al. Altered autophagy induction by sera from pregnant women with pre-eclampsia: A case-control study. BJOG. 2014;121(8):958–964.
   PubMed Web of Science ®Google Scholar
• Nakabayashi Y, Nakashima A, Yoshino O, et al. Impairment of the accumulation of decidual T cells, NK cells, and monocytes, and the poor vascular remodeling of spiral arteries, were observed in oocyte donation cases, regardless of the presence or absence of preeclampsia. J Reprod Immunol. 2016;114:65–74.
   PubMed Web of Science ®Google Scholar
• Akaishi R, Yamada T, Nakabayashi K, et al. Autophagy in the placenta of women with hypertensive disorders in pregnancy. Placenta. 2014;35(12):974–980.
   PubMed Web of Science ®Google Scholar
• Soleymanlou N, Jurisica I, Nevo O, et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005;90(7):4299–4308.
   PubMed Web of Science ®Google Scholar
• Asplund A, Stillemark-Billton P, Larsson E, et al. Hypoxic regulation of secreted proteoglycans in macrophages. Glycobiology. 2010;20(1):33–40.
   PubMed Web of Science ®Google Scholar
• Matsubara K. Hypoxia in the pathogenesis of preeclampsia. Hypertens Res Pregnancy. 2017;5:46–51.
   Web of Science ®Google Scholar
• Handler M, Yurchenco PD, Iozzo RV. Developmental expression of perlecan during murine embryogenesis. Dev Dyn. 1997;210(2):130–145.
   PubMed Web of Science ®Google Scholar
• Costell M. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol. 1999;147(5):1109–1122.
   PubMed Web of Science ®Google Scholar
• Wight TN. A role for proteoglycans in vascular disease. Matrix Biol. 2018;71–72:396–420.
   PubMed Web of Science ®Google Scholar
• Nonaka R, Iesaki T, de Vega S, et al. Perlecan deficiency causes endothelial dysfunction by reducing the expression of endothelial nitric oxide synthase. Physiol Rep. 2015;3(1):e12272.
   PubMed Web of Science ®Google Scholar
• Weissgerber TL, Garcia-Valencia O, Milic NM, et al. Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion. J Am Heart Assoc. 2019;8(4):e010647.
   PubMed Web of Science ®Google Scholar